424 related articles for article (PubMed ID: 10355070)
1. [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].
Fetsch T; Burschel G; Breithardt G; Engberding R; Koch HP; Lukl J; Trappe HJ; Treese N
Z Kardiol; 1999 Mar; 88(3):195-207. PubMed ID: 10355070
[TBL] [Abstract][Full Text] [Related]
2. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
[TBL] [Abstract][Full Text] [Related]
3. [Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].
Patten M; Koch HP; Sonntag F; Lüderitz B; Meinertz T
Z Kardiol; 1999 Mar; 88(3):185-94. PubMed ID: 10355069
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
Hohnloser SH; van de Loo A; Baedeker F
J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
[TBL] [Abstract][Full Text] [Related]
5. [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison].
Kalusche D; Stockinger J; Betz P; Roskamm H
Z Kardiol; 1994; 83 Suppl 5():109-16. PubMed ID: 7846939
[TBL] [Abstract][Full Text] [Related]
6. Event-recorder monitoring in the diagnosis of atrial fibrillation in symptomatic patients: subanalysis of the SOPAT trial.
Patten M; Maas R; Karim A; Müller HW; Simonovsky R; Meinertz T
J Cardiovasc Electrophysiol; 2006 Nov; 17(11):1216-20. PubMed ID: 16987384
[TBL] [Abstract][Full Text] [Related]
7. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
8. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?
Zardo F; Antonini-Canterin F; Brieda M; Hrovatin E; Pavan D; Burelli C; Cervesato E; Nicolosi GL
Ital Heart J; 2001 Jul; 2(7):513-8. PubMed ID: 11501960
[TBL] [Abstract][Full Text] [Related]
9. [PAFAC Study. Secondary prevention of atrial fibrillation after cardioversion].
Nitschmann S; Antz M; Kuck KH
Internist (Berl); 2005 Jul; 46(7):800-2. PubMed ID: 15947902
[No Abstract] [Full Text] [Related]
10. Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial.
Patten M; Maas R; Bauer P; Lüderitz B; Sonntag F; Dluzniewski M; Hatala R; Opolski G; Müller HW; Meinertz T;
Eur Heart J; 2004 Aug; 25(16):1395-404. PubMed ID: 15321697
[TBL] [Abstract][Full Text] [Related]
11. Early Detection of Symptomatic Paroxysmal Cardiac Arrhythmias by Trans-Telephonic ECG Monitoring: Impact on Diagnosis and Treatment of Atrial Fibrillation.
Anczykowski J; Willems S; Hoffmann BA; Meinertz T; Blankenberg S; Patten M
J Cardiovasc Electrophysiol; 2016 Sep; 27(9):1032-7. PubMed ID: 27257094
[TBL] [Abstract][Full Text] [Related]
12. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Frick M; Darpö B; Ostergren J; Rosenqvist M
Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
14. VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study).
De Simone A; De Pasquale M; De Matteis C; Canciello M; Manzo M; Sabino L; Alfano F; Di Mauro M; Campana A; De Fabrizio G; Vitale DF; Turco P; Stabile G
Eur Heart J; 2003 Aug; 24(15):1425-9. PubMed ID: 12909071
[TBL] [Abstract][Full Text] [Related]
15. Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation.
Senatore G; Stabile G; Bertaglia E; Donnici G; De Simone A; Zoppo F; Turco P; Pascotto P; Fazzari M
J Am Coll Cardiol; 2005 Mar; 45(6):873-6. PubMed ID: 15766823
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Lafuente-Lafuente C; Valembois L; Bergmann JF; Belmin J
Cochrane Database Syst Rev; 2015 Mar; (3):CD005049. PubMed ID: 25820938
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.
De Ferrari GM; Maier LS; Mont L; Schwartz PJ; Simonis G; Leschke M; Gronda E; Boriani G; Darius H; Guillamón Torán L; Savelieva I; Dusi V; Marchionni N; Quintana Rendón M; Schumacher K; Tonini G; Melani L; Giannelli S; Alberto Maggi C; Camm AJ;
Heart Rhythm; 2015 May; 12(5):872-8. PubMed ID: 25602175
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP
Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387
[TBL] [Abstract][Full Text] [Related]
19. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
Singh SN; Tang XC; Reda D; Singh BN
Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
[TBL] [Abstract][Full Text] [Related]
20. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
